Embryofetopathy due to oral anticoagulant therapy

Description

A condition caused by exposure of the embryo or fetus to anticoagulants during the antenatal period. This disease may present with optic nerve anomaly, optic atrophy, anomaly of the papilla, blindness, or choanal atresia.

Index terms

Embryofetopathy due to oral anticoagulant therapy
Fetal warfarin syndrome
Coumarin embryopathy

Show allHide

Vitamin K antagonists embryofetopathy
Dysmorphism due to warfarin

Exclusions from above levels

http://id.who.int/icd/entity/733825440 – Inborn errors of metabolism

Sibling codes

LD2F.00 – Fetal alcohol syndrome
LD2F.01 – Fetal hydantoin syndrome
LD2F.03 – Fetal Valproate Spectrum Disorder
LD2F.0Y – Other specified toxic or drug-related embryofetopathies
LD2F.0Z – Toxic or drug-related embryofetopathies, unspecified

Foundation entity

Embryofetopathy due to oral anticoagulant therapy – http://id.who.int/icd/entity/71579696

Part of: LD2F.0: Toxic or drug-related embryofetopathies › LD2F: Syndromes with multiple structural anomalies, without predominant body system involvement › 20: Developmental anomalies